Clinical Trial Update: FemVue and Tubal Patency [NA]

View source ↗

Summary

Clinical trial update for FemVue addressing tubal patency has been terminated; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tubal Patency

Drugs mentioned

• FemVue

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Tubal Patency | NA | Status: TERMINATED | Results posted: 2020-05-27